BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19670944)

  • 1. Understanding the medical device directive changes.
    McKenna C
    Biomed Instrum Technol; 2009; 43(4):319-20. PubMed ID: 19670944
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies in Italy.
    Donawa M
    Med Device Technol; 2009; 20(7):18-21. PubMed ID: 20058650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing changes during a clinical investigation, Part II.
    Donawa M
    Med Device Technol; 2003 Oct; 14(8):24-7. PubMed ID: 14603716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination products and the role of medical device firms.
    Etheredge R
    Biomed Instrum Technol; 2005; 39(2):143-6. PubMed ID: 15810788
    [No Abstract]   [Full Text] [Related]  

  • 8. What is in the QSR/GMP?
    Bartoo G;
    IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of the Medical Device Directive.
    Donawa M
    Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to kick-start your CAPA process.
    Peterson K
    Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk management of European device clinical studies.
    Donawa M
    Med Device Technol; 2007; 18(2):39-42. PubMed ID: 17494500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conducting clinical studies in Italy.
    Donawa M
    Med Device Technol; 2005 Oct; 16(8):21-4. PubMed ID: 16355966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance on submitting quality system information.
    Donawa ME
    Med Device Technol; 2004 Mar; 15(2):24-7. PubMed ID: 15154336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluations clinical investigations under the amended Medical Device Directive.
    Dannhorn DR; Schwabedissen H
    Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing US and European device testing requirements.
    Donawa M
    Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design controls.
    Bartoo G
    IEEE Eng Med Biol Mag; 2003; 22(2):112-4. PubMed ID: 12733469
    [No Abstract]   [Full Text] [Related]  

  • 17. Software as a medical device: regulatory critical issues.
    Pelayo S; Bras Da Costa S; Leroy N; Loiseau S; Beuscart-Zephir MC
    Stud Health Technol Inform; 2013; 183():337-42. PubMed ID: 23388310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An important step forward in the global harmonisation of premarket review programmes.
    Donawa M
    Med Device Technol; 2001 Sep; 12(7):28-30. PubMed ID: 12938557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical and regulatory issues in nonrandomized medical device clinical studies.
    Li H; Yue LQ
    J Biopharm Stat; 2008; 18(1):20-30. PubMed ID: 18161539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.